TET3 and ovarian carcinoma: Additionally, TET3 expression was decreased in ovarian cancer tissues, acted as a suppressor of ovarian cancer by demethylating miR-30d precursor gene promoter to block TGF-β1-induced epithelial-mesenchymal transition [28].